Medical News

< back to feeds
Headache/Migraine News
Migraine Raises Risk Of Most Common Form Of Stroke
Pooling results from 21 studies, involving 622,381 men and women, researchers at Johns Hopkins have affirmed that migraine headaches are associated with more than twofold higher chances of the most common kind of stroke: those occurring when blood supply to the brain is suddenly cut off by the buildup of plaque or a blood clot. The risk for those with migraines is 2.3 times those without, according to calculations from the Johns Hopkins team, to be presented Nov. ...more
17 Nov 2009
Molecular Imaging Pinpoints Inflammation In The Brains Of Schizophrenics And Migraine Sufferers
Inflammatory response of brain cells - as indicated by a molecular imaging technique - could tell researchers more about why certain neurologic disorders, such as migraine headaches and psychosis in schizophrenic patients, occur and provide insight into how to best treat them, according to two studies published in the November issue of The Journal of Nuclear Medicine. ...more
02 Nov 2009
Migraine With Aura Is Associated With Increased Risk Of Stroke
A migraine with aura occurs when temporary visual or sensory disturbances are experienced before or during a migraine headache. A study just published on bmj.com reports that migraine with aura is associated with a twofold increased risk of stroke. Further risk factors for stroke among patients with migraine are being a woman, being young, being a smoker, and using contraceptives containing estrogen. ...more
29 Oct 2009
Migraine With Aura Doubles The Risk Of Stroke
Migraine with aura (temporary visual or sensory disturbances before or during a migraine headache) is associated with a twofold increased risk of stroke, finds a study published on bmj.com today. Further risk factors for stroke among patients with migraine are being a woman, being young, being a smoker, and using oestrogen containing contraceptives. ...more
28 Oct 2009
Only Some Migraine Sufferers At Higher Risk Of Stroke
On the publication of research in the British Medical Journal looking at the links between migraine and an increased risk of stroke, Ellen Mason, Cardiac Nurse at the British Heart Foundation said: 'This review clarifies that it is only migraine with aura - a migraine with temporary visual and sensory disturbances that is linked to increased risk of having a stroke. ...more
28 Oct 2009
For Severe Migraine Headaches, Surgery Potentially The Best Option
The disability from migraine headaches is an enormous health burden affecting over 30 million Americans. In newly released research, 79 migraine sufferers were followed for at least five years after having undergone detection of migraine "trigger sites" and surgery. The new data finds promising outcomes for treating trigger sites surgically for migraine headaches resulting in elimination of pain for those afflicted with the condition. ...more
26 Oct 2009
Zogenix And Astellas Announce Data Published Showing The Benefits Of SUMAVEL(TM) DosePro(TM) Needle-Free Delivery System
Zogenix, Inc. ("Zogenix"), a privately held pharmaceutical company, and Astellas Pharma US, Inc. ("Astellas") announced that positive results from two clinical studies of new SUMAVEL DosePro (sumatriptan injection) needle-free delivery system will be published in the November 2009 issue of Headache. SUMAVEL DosePro, was recently approved by the FDA to treat acute migraine, with or without aura, and cluster headache. ...more
23 Oct 2009
57-Year-Old Plainfield Man Relieved Of Constant Migraine Pain Following New Cutting Edge Nerve Procedure
The Plastic Surgery Center announced that a 57-year-old Plainfield man reports he is free of constant headache pain after undergoing a new cutting edge nerve procedure to permanently eliminate pain caused by migraines. The procedure was performed by plastic and reconstructive surgeon Dr. Matthew Kaufman, of the Plastic Surgery Center in New Jersey on August 4, 2009. The surgery was performed on Mr. ...more
22 Oct 2009
Epilepsy Treatment Is A Possible Culprit For Development Of Schizophrenia
Researchers say antiepilectic drug treatments administered when the brain is developing appear to trigger schizophrenia-like behavior in animal models. In humans, having a history of seizures in infancy is a significant risk factor for development of schizophrenia later in life, but it is not known whether the elevated risk is due to seizures themselves, or from side effects antiepileptic drug (AED) treatment. ...more
21 Oct 2009
Migraine Sufferers More Prone To Hangover Headache
Migraine sufferers, beware. You may be more prone to an alcohol-induced headache after a night of drinking, according to researchers from the Jefferson Headache Center. The research will be presented at Neuroscience 2009, the Annual Meeting of the Society for Neuroscience, in Chicago. Until now, studying the mechanism behind migraine and other forms of recurrent headaches has not been possible in an animal model, according to Michael Oshinsky, Ph.D. ...more
19 Oct 2009
APP Pharmaceuticals Receives Approval For Sumatriptan Succinate Injection, USP
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ: APCVZ) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Sumatriptan Succinate Injection, USP, in two dosage strengths. Sumatriptan Succinate Injection is therapeutically equivalent to the reference-listed drug Imitrex®, which is marketed by the innovator GlaxoSmithKline. ...more
09 Oct 2009
Cocoa Enriched Diets May Be Beneficial In Treatment Of Migraine
For several years, researchers have been interested in the value of Theobroma cacao in treating a variety of disorders. A new study presented at the International Headache Society's 14th International Headache Congress hosted by the American Headache Society (AHS) in Philadelphia, has provided the first evidence for the value of cocoa as a dietary supplement in repressing inflammatory responses within the trigeminal ganglia which are thought to play a role in migraine. ...more
16 Sept 2009
Migraine Patients Who Experience Aura May Have A Two-Fold Increased Risk For Ischemic Stroke
A systematic review and meta-analysis of case-control and cohort studies finds that patients with migraine with aura have a two-fold increased risk for ischemic stroke compared to non-migraineurs. This association does not appear among migraineurs without aura[i]. Migraine with aura is often characterized by visual disturbances such as flashes of light, zigzagging patterns or even blind spots, which are then followed by a migraine attack. ...more
16 Sept 2009
Going To Work With A Migraine? New Study Says Work Productivity Is The Same As Staying Home
Employees who go to work with a migraine or stay on the job when they get an attack may be less productive than if they stayed home, according to a new study presented at the 2009 International Headache Congress (IHC) in Philadelphia, hosted by the American Headache Society (AHS). ...more
16 Sept 2009
Scientific Studies Confirm The Value Of Botulinum Toxin Type A (Botox) In Treating And Preventing Chronic Migraine
Four separate studies[i] representing the findings of clinical trials in the U.S., Canada and Europe have confirmed the value of onabotulinumtoxinA in treating and preventing chronic migraine in adults. These studies found that treatment with botulinum toxin type A was associated with significantly fewer headache days, less headache-related disability, and significantly improved quality of life. ...more
16 Sept 2009
Winners Of 2009 Research Grants Announced By Migraine Research Foundation
The Migraine Research Foundation (MRF), the only nonprofit organization devoted solely to funding migraine research, has announced the winners of the 2009 research grants. This year's grantees will explore such important areas as pediatric migraine, the genetic association between migraine and cardiovascular events, and why opioids enhance migraine pain. ...more
07 Sept 2009
NovaDel Article Published In Headache: The Journal Of Head And Face Pain
NovaDel Pharma Inc. (NYSE AMEX: NVD) announced that an article titled "Rapid Oral Transmucosal Absorption of Sumatriptan, and Pharmacodynamics in Acute Migraine" was published online on June 22, 2009 in the peer-reviewed journal Headache: The Journal of Head and Face Pain. NovaDel conducted two clinical trials evaluating sumatriptan administered via its oral spray drug delivery technology. ...more
03 Sept 2009
Leading International Headache Journal Cephalalgia To Be Published By SAGE
SAGE, the world's leading independent academic and professional publisher is delighted to announce a new agreement with the International Headache Society (IHS) to publish their official journal, Cephalalgia. Now in its 29th volume, Cephalalgia provides an international forum for original research papers, review articles and short communications on all aspects of headache. ...more
03 Sept 2009
Kids' Headaches, Migraines Increase As New School Year Begins
As children and teens begin school again, they are more susceptible to the pain and discomfort of headaches and migraines. The change in schedule, new teachers, new friends and schoolwork can increase stress and consequently, increase headaches. Doctors at Nationwide Children's Hospital say there are some steps parents can take to help prevent the onset of their headaches during this hectic time of year. ...more
29 Aug 2009
What Is Aspirin? What Is Aspirin For?
Aspirin, or acetylsalicylic acid (ASA) is a salicylate drug, and is generally used as an analgesic (something that relieves pain without producing anesthesia or loss of consciousness) for minor aches and pains, to reduce fever (an antipyretic), and also as an anti-inflammatory drug. Aspirin has also become increasingly popular as an antiplatelet - used to prevent blood clot formation - in long-term low doses to prevent heart attacks and strokes in high risk patients. ...more
20 Aug 2009

Pages of Results:   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 [Next] [Last Page]
Headache/Migraine News courtesy of Medical News Today back to top